Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

Abroad (travel likely)RecruitingPHASE1

Conditions

Ovary Neoplasm · Ovarian Cancer · Epithelial Ovarian Cancer · Recurrent

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Caroline Babinec) · Caroline_babinec@med.unc.edu
Contact: Principal Investigator (Linda Van Le)

Study leads

Linda Van Le, MD
Principal Investigator
UNC Lineberger Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer

Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Solid Tumor, Adult · Bladder Cancer · Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

North Melbourne, Australia

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Metastatic Colorectal Cancer · Metastatic Pancreatic Cancer · Metastatic Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States